Does Rallies show 13F holders for HUM?

Yes. Rallies tracks hedge fund and 13F ownership data for HUM, including fund names, share counts, latest tracked quarter, and position changes when available.

Is HUM research on Rallies investment advice?

No. Rallies provides research, data, and educational context for HUM. It does not provide personalized investment advice.

HUM (Humana) Stock Analysis - Hedge Fund Holdings

Humana (HUM) is a publicly traded Healthcare sector company. As of May 20, 2026, HUM trades at $307.98 with a market cap of $36.74B and a P/E ratio of 32.86. HUM moved -1.34% today. Year to date, HUM is +17.42%; over the trailing twelve months it is +25.56%. Its 52-week range spans $163.11 to $324.38. Analyst consensus is neutral with an average price target of $241.18. Rallies surfaces HUM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns HUM stock?

Hedge funds tracked by Rallies that own HUM include GQG Partners, Viking Global, Baupost Group, Glenview Capital, and Maverick Capital. The latest tracked quarter is Dec 31, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Humana.

HUM Key Metrics

Key financial metrics for HUM
Metric	Value
Price	$307.98
Market Cap	$36.74B
P/E Ratio	32.86
EPS	$9.39
Dividend Yield	0.89%
52-Week High	$324.38
52-Week Low	$163.11
Volume	589.38K
Avg Volume	0
Revenue (TTM)	$137.20B
Net Income	$1.15B
Gross Margin	0.00%

Top Hedge Funds Holding HUM

GQG Partners holds 618.91K shares of HUM, changed +0.00% as of Dec 31, 2023.
Viking Global holds 464.13K shares of HUM, changed +0.00% as of Mar 31, 2024.
Baupost Group holds 346.00K shares of HUM, changed -17.62% as of Dec 31, 2024.
Glenview Capital holds 334.89K shares of HUM, changed +0.00% as of Mar 31, 2026.
Maverick Capital holds 197.89K shares of HUM, changed +3.30% as of Sep 30, 2024.

Latest HUM News

Deutsche Bank Doubles Humana Price Target to $441, Cites 2026 Rebound — May 20, 2026
Humana Shares Outperform Healthcare Peers as Market Dips — May 12, 2026
Humana jumps as Q1 results and reaffirmed 2026 outlook drive analyst re-ratings — May 6, 2026
Humana Adds 50,000 Medicaid Members, Issues $1B Notes as Medicare Advantage Margins Set to Double — Apr 30, 2026
Humana Q1 EPS $10.31 Beats Estimates, Benefit Ratio at 89.4% — Apr 29, 2026

Recent HUM Insider Trades

Shetty Sanjay K bought 810 (~$150.02K) on Feb 23, 2026.

HUM Analyst Consensus

20 analysts cover HUM: 0 strong buy, 6 buy, 12 hold, 2 sell, 0 strong sell. Consensus rating is neutral. Average price target: $241.18.

Common questions about HUM

Who owns HUM stock?: Hedge funds tracked by Rallies that own HUM include GQG Partners, Viking Global, Baupost Group, Glenview Capital, and Maverick Capital. The latest tracked quarter is Dec 31, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Humana.
Does Rallies show 13F holders for HUM?: Yes. Rallies tracks hedge fund and 13F ownership data for HUM, including fund names, share counts, latest tracked quarter, and position changes when available.
Is HUM research on Rallies investment advice?: No. Rallies provides research, data, and educational context for HUM. It does not provide personalized investment advice.